Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
HFA MDI
DRUG:
HFO MDI
Sponsor
AstraZeneca